SEC filings and other documents

Explore the latest company documents and SEC filings from the company, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

2025

Earnings, Q4 FY2025

Jan 30, 2026

Revenue plunged 61% and net loss deepened to RMB12.8 million amid weak demand and rising credit losses.

Investor Presentation

Jul 11, 2025

Apparel SCM firm targets $15–$17.5M Nasdaq IPO, focusing on growth, efficiency, and sustainability.

Ping An Biomedical Co., Ltd.

SEC filings and other documents